Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Predictors of ICU Admission of Obstetric Posterion Reversible Encephalopathy Syndrome

NCT05310513 is registered in ClinicalTrials.gov with Dunjin Chen as lead sponsor.

NCT NCT05310513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05310513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Predictors of ICU Admission of Obstetric Posterion Reversible Encephalopathy Syndrome
Lead sponsor
Dunjin Chen
Phase
Observational
Overall status
Completed
Start date
April 1, 2022
Completion date
May 31, 2022
Enrollment
366 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care units, posterior reversible encephalopathy syndrome